AIM:To test the efficacy of a proprietary nutraceutical combination in reducing insulin resistance associated with the metabolic syndrome(MetS).METHODS:Sixty-fo
Aims: Data on long-term efficacy of bosentan in unselected idiopathic pulmonary arterial hypertension(IPAH) patients are lacking. We aimed to describe the long-